Presentation Exenatide Reduces Final Infarct Size in Pts with STEMI and Short Duration of Ischemia Presenter: Jacob L?nborg April 13, 2012
Presentation GI2 2012 How to Reduce Contrast Induced Nephropathy in Interventional Procedures Presenter: Ron Waksman April 13, 2012
Presentation GI2 2012 10 Reasons Why the Metallic Drug-eluting Stent Should be Replaced by Bioresorbable Scaffold Presenter: Patrick W. Serruys April 12, 2012
Presentation GI2 2012 Drug-Eluting Balloon: Clinical Evidence for In-Stent Restenosis Presenter: Marco V. Wainstein April 12, 2012
Presentation GI2 2012 Bioabsorbable Scaffold: New and Evolving Designs Presenter: Alexandre Abizaid April 12, 2012
Presentation GI2 2012 Pathology of DES with Biodegradable Polymer: Are They Really Better? Presenter: Renu Virmani April 12, 2012
Presentation GI2 2012 New Agents and Prevention of Contrast Induced Nephropathy Presenter: George Dangas April 12, 2012
Presentation GI2 2012 How to Improve TAVR Safety? The Role of Ancillary Devices Presenter: Martin B. Leon April 12, 2012